Toxic debate over lab leak theory hampers search for Covid origins
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
Similar Posts
Rishi Sunak: Weekly fast is important discipline for me
The PM says fasting at the beginning of the week means he can “indulge” in sugary treats at other times.
Cancer is now leading cause of death among HIV-positive people, report says: ‘Of great concern’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Renewed interest in ADCs will continue in 2024
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead….
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…
Covid inquiry: Failure to consider 'potentially massive impact' of lockdown pre-pandemic
The UK may not have been well prepared “at all”, says the lead lawyer for the Covid inquiry.
Humana reports grim 2024 forecast due to soaring medical costs
Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday after the health insurer issued dismal full-year earnings guidance,…